SCHEMBL9255248

SCHEMBL9255248

COC(=O)CCNC(=O)c1cc2nc(-c3ccc(C#N)cc3)n(C)c2cc1N(C)C(=O)OCC(C)C

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.37
PRSS12 P56730 1/20 0.35
EGLN1 Q9GZT9 2/20 0.34
ITK Q08881 8/20 0.34
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
PIN1 Q13526 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
GCGR P47871 1/20 0.32
SCN9A Q15858 1/20 0.32
EGLN2 Q96KS0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9252454 0.87 PRSS12 (0.38) PRSS12JAK2JAK1TYK2JAK3
SCHEMBL9248585 0.85 EGLN1 (0.37) IRAK4PRSS12EGLN1ITKJAK2
SCHEMBL9252129 0.81 IRAK4 (0.41) IRAK4PRSS12EGLN1ITKJAK2
SCHEMBL9255968 0.76 HDAC1 (0.51) EGLN1ITKJAK2JAK1TYK2
SCHEMBL9256882 0.74 CHEK2 (0.38) PRSS12HDAC3HDAC1HDAC2HDAC8
Hydrochloric Acid SCHEMBL9246087 0.71 CHEK2 (0.36) PRSS12HDAC3HDAC1HDAC2HDAC8
SCHEMBL9256202 0.70 JAK2 (0.55) ITKJAK2JAK1TYK2JAK3
SCHEMBL9250822 0.70 ADORA2A (0.46) IRAK4EGLN1JAK2JAK1TYK2
SCHEMBL9245464 0.69 HDAC6 (0.48) PRSS12HDAC3HDAC1HDAC2HDAC8
SCHEMBL9253691 0.68 JAK2 (0.60) ITKJAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5434150-A Anticoagulants, cardiovascular disorders DR. KARL THOMAE GMBH (DE) 1995-07-18 US disclosed
EP-0531883-A1 Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-03-17 EP disclosed